Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick A Bright

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Vaccines|March 27, 2026
mRNA and Next-Generation Vaccine Platforms for Pandemic Influenza PreparednessRick A Bright
The Journal of Infectious Diseases|October 16, 2025
Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic FrameworkRick A Bright
BMJ (Clinical Research Ed.)|December 23, 2024
Governing global health with a planetary mindsetIlona Kickbusch, Rick A Bright
JAMA Network Open|October 29, 2025
Asymptomatic Influenza A(H5N1) Infections and Sustained Surveillance-Sustaining Surveillance Beyond the CrisisRick A Bright, Nicole Lurie
The Journal of Infectious Diseases|August 14, 2009
Influenza vaccine manufacture: keeping up with changeKathleen M Neuzil, Rick A Bright
Vaccine|June 21, 2011
United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing worldMichael L Perdue, Rick A Bright
JAMA|January 6, 2022
A National Strategy for COVID-19: Testing, Surveillance, and Mitigation StrategiesDavid Michaels, Ezekiel J Emanuel, Rick A Bright
Influenza and Other Respiratory Viruses|January 3, 2013
Antivirals in seasonal and pandemic influenza--future perspectivesMichael W Wathen, Mario Barro, Rick A Bright
NAM Perspectives|January 20, 2025
AI-Enabled Protein Design: A Strategic Asset for Global Health and BiosecurityLynda M Stuart, Rick A Bright, Eric Horvitz
JAMA|September 4, 2024
H5 Influenza Vaccines-Moving Forward Against Pandemic ThreatsJesse L Goodman, Rick A Bright, Nicole Lurie
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Vaccines|March 27, 2026
mRNA and Next-Generation Vaccine Platforms for Pandemic Influenza PreparednessRick A Bright
The Journal of Infectious Diseases|October 16, 2025
Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic FrameworkRick A Bright
BMJ (Clinical Research Ed.)|December 23, 2024
Governing global health with a planetary mindsetIlona Kickbusch, Rick A Bright
JAMA Network Open|October 29, 2025
Asymptomatic Influenza A(H5N1) Infections and Sustained Surveillance-Sustaining Surveillance Beyond the CrisisRick A Bright, Nicole Lurie
The Journal of Infectious Diseases|August 14, 2009
Influenza vaccine manufacture: keeping up with changeKathleen M Neuzil, Rick A Bright
Vaccine|June 21, 2011
United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing worldMichael L Perdue, Rick A Bright
JAMA|January 6, 2022
A National Strategy for COVID-19: Testing, Surveillance, and Mitigation StrategiesDavid Michaels, Ezekiel J Emanuel, Rick A Bright
Influenza and Other Respiratory Viruses|January 3, 2013
Antivirals in seasonal and pandemic influenza--future perspectivesMichael W Wathen, Mario Barro, Rick A Bright
NAM Perspectives|January 20, 2025
AI-Enabled Protein Design: A Strategic Asset for Global Health and BiosecurityLynda M Stuart, Rick A Bright, Eric Horvitz
JAMA|September 4, 2024
H5 Influenza Vaccines-Moving Forward Against Pandemic ThreatsJesse L Goodman, Rick A Bright, Nicole Lurie
Pageof 5